CÇü ¹× SÇü ´Ü¹é °áÇÌ¿¡ ÀÇÇÑ Ç÷°ü Áúȯ
Vascular Diseases Associated with Protein C and/or S Deficiencies
Á¶¿ëÇÊ, ÀÌ´öÈñ, Á¤½Â¹®, ÀåÇõÀç, ±èÁö¼ö, ÇѸí½Ä,
¼Ò¼Ó »ó¼¼Á¤º¸
Á¶¿ëÇÊ ( Cho Yong-Pil )
¾Æ»êÀç´Ü °¸ªº´¿ø ¿Ü°úÇб³½Ç
ÀÌ´öÈñ ( Lee Deok-Hee )
¾Æ»êÀç´Ü °¸ªº´¿ø Áø´Ü¹æ»ç¼±°úÇб³½Ç
Á¤½Â¹® ( Jung Seung-Mun )
¾Æ»êÀç´Ü °¸ªº´¿ø Áø´Ü¹æ»ç¼±°úÇб³½Ç
ÀåÇõÀç ( Jang Hyuk-Jai )
¾Æ»êÀç´Ü °¸ªº´¿ø ¿Ü°úÇб³½Ç
±èÁö¼ö ( Kim Ji-Su )
¾Æ»êÀç´Ü °¸ªº´¿ø ¿Ü°úÇб³½Ç
ÇѸí½Ä ( Han Myoung-Sik )
¾Æ»êÀç´Ü °¸ªº´¿ø ¿Ü°úÇб³½Ç
KMID : 0371320020620020181
Abstract
Purpose: There are a number of conditions that can lead to a
hypercoagulable state, however, protein C and S deficiencies are frequently
described as causes of the hypercoagulable states. The aim of this study was
to evaluate the clinical features and prognosis of vascular diseases
associated with protein C and/or S deficiencies and to determine an adequate
treatment modality for such cases. Methods: We prospectively
evaluated 7 cases with vascular disease caused by protein C and/or S
deficiencies confirmed with serologic tests. Results: Four patients
showed venous thrombosis, 1 peripheral arterial insufficiency, 1 cerebral
venous thrombosis and peripheral arterial insufficiency, and 1 portal vein
thrombosis. Surgical intervention was required in 5 patients. Full
anticoagulation with heparin sodium followed by warfarin sodium was done in
all patients. Conclusion: Protein C and S deficiencies may influence
clinical management. Patients presenting with atypical vascular involvement
without evidence of other risk factors should be evaluated for a
hypercoagulable state. Once the diagnosis is made, patients should be
treated with full anticoagulation.
Å°¿öµå
CÇü ¹× SÇü ´Ü¹é °áÇÌ; °úÀÀ°í »óÅÂ; Ç÷°üÁúȯ; Protein C and S deficiencies; Hypercoagulable state; Vascular diseases;
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸